News
Bloomberg on MSN2h
Trump anuncia plan para bajar precios de medicamentos y golpea al sector farmacéuticoLas acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...
Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...
President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, ...
Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...
My shift schedule allowed me to allocate time to complete my third-level education - a biopharmaceutical processing degree at ...
A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a ...
The U.S. Food and Drug Administration (FDA) on Monday cleared the amendment to Lantern Pharma Inc.’s (NASDAQ:LTRN) Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 in a ...
WASHINGTON] President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay ...
In a post on his Truth Social platform on Sunday, Trump said the order, to be signed at 9 a.m. Monday, will institute a "most favored nation" policy where the U.S. will pay the same price for ...
The US pays the highest prices for prescription drugs — often nearly three times more than other developed nations. Trump has repeatedly pledged to close the gap and made a similar attempt during his ...
Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced first quarter 2025 financial results and provided a business update. "Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results